Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Exploring Psilocybin Treatments in Underserved Indications
30 juil. 2021 08h30 HE
|
Tryp Therapeutics Inc.
NEW YORK, July 30, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of a broadcast titled, “Psychedelics — Not Just for Mental...
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Developing Evidence-Based Innovation Where Drugs Are Lacking
28 juil. 2021 08h30 HE
|
Tryp Therapeutics Inc.
NEW YORK, July 28, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
Global Organ On Chip Market Estimated to Garner Noteworthy Revenue of $6,97,654.30 Million by 2028 at a CAGR of 37.60% from 2021-2028 – Exclusive Report [180 Pages] By Research Dive
19 juil. 2021 09h05 HE
|
Research Dive
New York, USA, July 19, 2021 (GLOBE NEWSWIRE) -- The latest report by Research Dive states that the global organ on chip market is expected to witness a significant rise in revenue from $54,640.00...
Global Biological Sample Handling Market (2020 to 2026) - Featuring Alliance Pharma, Abbott Laboratories and Thermo Fisher Scientific Among Others
16 juil. 2021 07h13 HE
|
Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Biological Sample Handling Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global biological sample handling market...
Latin America $768 Million Digital Biology Market to 2027: Growing R&D Costs and Clinical Trial Failure Rates have Driven Demand for Computational Biology-based Solutions
16 juil. 2021 04h48 HE
|
Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Latin America Digital Biology Market Size, Share & Trends Analysis Report by Application (Drug Discovery & Disease Modelling), by Tools, by...
Modular Facilities in Pharmaceutical and Biotechnology Global Market to 2030 - Featuring Cytiva, NNE And IPM Technologies Among Others
13 juil. 2021 05h23 HE
|
Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Modular Facilities in Pharmaceutical and Biotechnology Market: Industry Trends and Global Forecasts, 2021-2030" report has been added to...
Global Synthetic Biology Market Research Report 2021-2026: Increase in the Demand for Protein Therapeutics and Personalized Medicines & Growth in Research on Synthetic Drugs and Vaccines
08 juil. 2021 03h08 HE
|
Research and Markets
Dublin, July 08, 2021 (GLOBE NEWSWIRE) -- The "Global Synthetic Biology Market Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global synthetic biology market...
Sosei Heptares and InveniAI Enter a Multi-Target AI-Powered and GPCR-Focused Drug Discovery Collaboration
06 juil. 2021 08h10 HE
|
InveniAI LLC
Collaboration to create transformative therapeutics for immune diseases by combining InveniAI's validated AI-based platform, AlphaMeld®, with Sosei Heptares' GPCR Structure-based Drug Design and early...
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space
30 juin 2021 08h30 HE
|
Tryp Therapeutics Inc.
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions
23 juin 2021 19h00 HE
|
Certara
PRINCETON, N.J., June 23, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its...